Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like <b>Vicarius Pharma</b> Launches With $21.8 Million and Will be Helmed by Former Biogen-Elan Exec August 13, 2017 Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest November 29, 2017 Is Medtronic's Artificial Pancreas The Next Big Thing In Diabetes? April 13, 2017
<b>Vicarius Pharma</b> Launches With $21.8 Million and Will be Helmed by Former Biogen-Elan Exec August 13, 2017
